Therapeutic efficacy and safety of Compound Kushen Injection combined with transarterial chemoembolization in unresectable hepatocellular carcinoma: An update systematic review and meta-analysis

Background: Compound Kushen Injection (CKI) is a Chinese patent medicine approved by the Chinese State Food and Drug Administration for the treatment of various types of solid tumors. CKI, combined with transarterial chemoembolization (TACE), is believed to increase the therapeutic efficacy of unres...

Full description

Saved in:
Bibliographic Details
Main Authors: Xiao eMa, Ruisheng eLi, Jian eWang, Yinqiu eHuang, Pengyan eLi, Ji eWang, Haibin eSu, Ruilin eWang, Yaming eZhang, Honghong eLiu, Congen eZhang, Zhijie eMa, Jiabo eWang, Yanling eZhao, Xiaohe eXiao
Format: Artigo
Language:Inglês
Published: Frontiers Media S.A. 2016-03-01
Series:Frontiers in Pharmacology
Subjects:
Meta-analysis
Systematic review
Transarterial chemoembolization
Compound kushen injection
Unresectable hepatocellular carcinoma
Online Access:http://journal.frontiersin.org/Journal/10.3389/fphar.2016.00070/full
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items